Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Effects of calcium channel blocker benidipine-based combination therapy on target blood pressure control and cardiovascular outcome: a sub-analysis of the COPE trial.

Umemoto S, Ogihara T, Matsuzaki M, Rakugi H, Ohashi Y, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial Group.

Hypertens Res. 2017 Apr;40(4):376-384. doi: 10.1038/hr.2016.158. Epub 2016 Dec 1.

2.

Combination therapy for hypertension in the elderly: a sub-analysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial.

Ogihara T, Matsuzaki M, Umemoto S, Rakugi H, Matsuoka H, Shimada K, Higaki J, Ito S, Kamiya A, Suzuki H, Ohashi Y, Shimamoto K, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial Group.

Hypertens Res. 2012 Apr;35(4):441-8. doi: 10.1038/hr.2011.216. Epub 2012 Jan 26.

PMID:
22278623
3.

Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension: a randomized controlled trial.

Matsuzaki M, Ogihara T, Umemoto S, Rakugi H, Matsuoka H, Shimada K, Abe K, Suzuki N, Eto T, Higaki J, Ito S, Kamiya A, Kikuchi K, Suzuki H, Tei C, Ohashi Y, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial Group.

J Hypertens. 2011 Aug;29(8):1649-59. doi: 10.1097/HJH.0b013e328348345d.

PMID:
21610513
4.

Effects of Calcium-Channel Blocker Benidipine-Based Combination Therapy on Cardiac Events - Subanalysis of the COPE Trial.

Umemoto S, Ogihara T, Matsuzaki M, Rakugi H, Shimada K, Kawana M, Kario K, Ohashi Y, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial Group.

Circ J. 2018 Jan 25;82(2):457-463. doi: 10.1253/circj.CJ-17-0592. Epub 2017 Sep 2.

5.

Combination therapy for hypertension in patients with CKD: a subanalysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events trial.

Rakugi H, Ogihara T, Umemoto S, Matsuzaki M, Matsuoka H, Shimada K, Higaki J, Ito S, Kamiya A, Suzuki H, Ohashi Y, Shimamoto K, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial Group.

Hypertens Res. 2013 Nov;36(11):947-58. doi: 10.1038/hr.2013.63. Epub 2013 Jul 18.

PMID:
23864054
6.

Effects of calcium channel blocker-based combinations on intra-individual blood pressure variability: post hoc analysis of the COPE trial.

Umemoto S, Ogihara T, Matsuzaki M, Rakugi H, Ohashi Y, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events COPE Trial Group.

Hypertens Res. 2016 Jan;39(1):46-53. doi: 10.1038/hr.2015.104. Epub 2015 Oct 22.

7.

Effects of a benidipine-based combination therapy on the risk of stroke according to stroke subtype: the COPE trial.

Umemoto S, Ogihara T, Rakugi H, Matsumoto M, Kitagawa K, Shimada K, Higaki J, Ito S, Suzuki H, Ohashi Y, Saruta T, Matsuzaki M; Combination Therapy of Hypertension to Prevent Cardiovascular.

Hypertens Res. 2013 Dec;36(12):1088-95. doi: 10.1038/hr.2013.100. Epub 2013 Aug 29.

PMID:
23985703
8.
10.

Effect of antihypertensive treatment on cardiovascular events in elderly hypertensive patients: Japan's Benidipine Research on Antihypertensive Effects in the Elderly (J-BRAVE).

Saito I, Suzuki H, Kageyama S, Saruta T.

Clin Exp Hypertens. 2011;33(2):133-40. doi: 10.3109/10641963.2010.546467. Epub 2011 Jan 26.

PMID:
21269056
11.

Renoprotective effect and cost-effectiveness of using benidipine, a calcium channel blocker, to lower the dose of angiotensin receptor blocker in hypertensive patients with albuminuria.

Saito F, Fujita H, Takahashi A, Ichiyama I, Harasawa S, Oiwa K, Takahashi N, Otsuka Y, Uchiyama T, Kanmatsuse K, Kushiro T.

Hypertens Res. 2007 Jan;30(1):39-47.

PMID:
17460370
12.

Comparison of combination therapies, including the angiotensin receptor blocker olmesartan and either a calcium channel blocker or a thiazide diuretic, in elderly patients with hypertension.

Kato J, Yokota N, Tamaki N, Kariya S, Kita T, Ayabe T, Eto T, Kitamura K.

Hypertens Res. 2011 Mar;34(3):331-5. doi: 10.1038/hr.2010.233. Epub 2010 Dec 2.

PMID:
21124326
14.

One-year results of an open-label study on antiproteinuric effect of benidipine in elderly patients with chronic kidney disease.

Tomino Y, Shimizu Y, Hamada C, Kurusu A, Ohsawa I, Suzuki Y, Tsuge T, Io H, Kobayashi N, Takeda Y, Asanuma K, Tanaka Y, Suzuki H, Nakata J, Takara K, Horikoshi S.

J Nephrol. 2011 Nov-Dec;24(6):756-63. doi: 10.5301/JN.2011.6383.

PMID:
21360472
15.

Comparison between the antiproteinuric effects of the calcium channel blockers benidipine and cilnidipine in combination with angiotensin receptor blockers in hypertensive patients with chronic kidney disease.

Abe M, Okada K, Maruyama N, Matsumoto S, Maruyama T, Fujita T, Matsumoto K, Soma M.

Expert Opin Investig Drugs. 2010 Sep;19(9):1027-37. doi: 10.1517/13543784.2010.505918.

PMID:
20649501
16.

Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension.

Ishimitsu T, Numabe A, Masuda T, Akabane T, Okamura A, Minami J, Matsuoka H.

Hypertens Res. 2009 Nov;32(11):962-8. doi: 10.1038/hr.2009.133. Epub 2009 Aug 21.

PMID:
19696778
17.

Benidipine has effects similar to losartan on the central blood pressure and arterial stiffness in mild to moderate essential hypertension.

Ihm SH, Jeon HK, Chae SC, Lim DS, Kim KS, Choi DJ, Ha JW, Kim DS, Kim KH, Cho MC, Baek SH; BELASCO trial investigators, Republic of Korea.

Chin Med J (Engl). 2013;126(11):2021-8.

PMID:
23769551
18.

Effects of combination of angiotensin receptor blocker and calcium channel blocker on ox-LDL levels and cardiovascular dysfunction in Dahl rats.

Takayama M, Arakawa E, Yao K, Ina Y, Sato H, Hasegawa K, Kohno H, Ohno T.

Pharmacology. 2006;77(4):179-87. Epub 2006 Jul 20.

PMID:
16864986
19.

Effects of short- and long-acting calcium channel blockers on the relationship between blood pressure and physical activity.

Kakinoki S, Nomura A, Takechi S, Kitabatake A.

Am J Hypertens. 2001 Jan;14(1):66-9.

PMID:
11206682
20.

Angiotensin System Blockade Combined With Calcium Channel Blockers Is Superior to Other Combinations in Cardiovascular Protection With Similar Blood Pressure Reduction: A Meta-Analysis in 20,451 Hypertensive Patients.

Chi C, Tai C, Bai B, Yu S, Karamanou M, Wang J, Protogerou A, Blacher J, Safar ME, Zhang Y, Xu Y.

J Clin Hypertens (Greenwich). 2016 Aug;18(8):801-8. doi: 10.1111/jch.12771. Epub 2016 Jan 17.

Supplemental Content

Support Center